Document Detail


Movement disorders in pregnancy.
MedLine Citation:
PMID:  15474767     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Movement disorders are not particularly common during pregnancy, with a few exceptions. RLS occurs most commonly followed by CG. Currently, with the incidence of rheumatic fever lower than previously, any woman who develops CG should be checked for illness other than rheumatic heart disease. The differential includes systemic lupus erythromatosis and antiphospholipid antibody syndrome. Regarding the use of dopaminergic agents, the dopamine agonist, pergolide, can be maintained during pregnancy for the treatment of PD, Segawa disease, and RLS. The use of levodopa and ropinirole should be limited during pregnancy because of the possible teratogenic effects. Amantadine is contraindicated during pregnancy. The data on selegiline are controversial; animal studies show possible serotonergic effects and teratogenic effects. If treatment is indicated in patients who have Tourette syndrome, the high potency neuroleptics drugs (haloperidol) are preferred to treat associated symptoms. Depression is a common comorbidity in patients who have PD, HD,Tourette syndrome, or other chronic neurologic diseases. Depression treatment during pregnancy is covered by Levy et al elsewhere in this issue. As discussed previously, most of the data on the use of drugs during pregnancy, especially the dopaminergic agents, are limited to animal studies and case reports. Therefore, it is in part left to the neurologist to decide on treatment based on the individual patient, clinical judgment, and inferences from animal studies and limited case reports.
Authors:
Marsha S A Smith; Marian L Evatt
Related Documents :
18677577 - Ghrelin and obestatin levels in rheumatoid arthritis.
16487877 - Physiological and biological skin changes in pregnancy.
8203427 - Three consecutive pregnancies in a patient with glycogen storage disease type ia (von g...
2351317 - Non-hodgkin's lymphomas and pregnancy: presentation of 16 cases.
16827957 - Therapeutic termination of second trimester pregnancies with low dose misoprostol.
17314487 - Evaluation of smoking as a risk factor for activated protein c resistance during pregna...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Neurologic clinics     Volume:  22     ISSN:  0733-8619     ISO Abbreviation:  Neurol Clin     Publication Date:  2004 Nov 
Date Detail:
Created Date:  2004-10-11     Completed Date:  2005-02-08     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8219232     Medline TA:  Neurol Clin     Country:  United States    
Other Details:
Languages:  eng     Pagination:  783-98     Citation Subset:  IM    
Affiliation:
Emory University School of Medicine, Atlanta, GA, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antipsychotic Agents / therapeutic use
Dopamine Antagonists / therapeutic use
Female
Humans
Movement Disorders / classification,  drug therapy,  physiopathology*
Pregnancy
Pregnancy Complications
Chemical
Reg. No./Substance:
0/Antipsychotic Agents; 0/Dopamine Antagonists

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Myasthenia gravis and pregnancy.
Next Document:  Pregnancy in women who have epilepsy.